Descovy is a brand-name oral tablet prescribed for HIV and to decrease the risk of contracting HIV. Descovy has boxed warnings. A boxed warning is the most serious warning from the Food and Drug ...

Descovy (emtricitabine/tenofovir alafenamide) is a brand-name oral tablet prescribed for preexposure prophylaxis (PrEP) in certain people at risk of developing HIV. Descovy also treats HIV in ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Descovy is approved for PrEP in transgender women and men who have sex with men. However, the drug is not approved for PrEP in females at risk of HIV from vaginal sex. The first studies of Descovy ...

The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile compared ...

Gilead’s Descovy got a green light from an FDA advisory committee for HIV pre-exposure prophylaxis (PrEP) yesterday – but as expected its use in women was a point of contention. Descovy ...